PRA International
RALEIGH, North Carolina, May 20, 2011 - PRA International, a leading Clinical Research Organization, announces
our recent acquisition of Kinship Technologies, a Chennai, India-based
software developer and services company.
RALEIGH, North Carolina, March 29, 2011 - PRA International, a leading Clinical Research Organization, announces
that two of our operational experts will conduct country-focused roundtable
sessions at the 4th Annual BioPharma Asia Convention being held in Singapore
28-31 March 2011.
RALEIGH, North Carolina, February 9, 2011 - PRA International, a leading Clinical Research Organization, announces
the opening of new offices in Israel and the Ukraine to accommodate the
firm's continued global expansion and enhance our offerings for clients.
RALEIGH, North Carolina, October 8, 2010 - PRA International, a leading Clinical Research Organization, will exhibit
its comprehensive oncology study experience and expertise at the European
Society for Medical Oncology's 35th annual congress to be held 9-12 October
2010 in Milan, Italy.
RALEIGH, North Carolina, September 13, 2010 - PRA International, a leading Clinical Research Organization, announces
that two of its leading drug safety experts will present at the 4th annual
World Drug Safety Congress to be held in London 14 -17 September 2010.
More News
- Opportunity to Meet with PRA Experts
- Hani Zaki Appointed to Leadership Role
- Join Us to Explore the Latest Issues in Hematology Trials
- Clinical Trials: Why is India Irresistible?
- Improved Monitoring and Increased Sponsor Access to Data are Key Benefits
- Bieker Remains on Board of Directors
- PRA International Experts Present a Session at the 8th Annual Partnerships in Clinical Trials 2009
- PRA International Recognized at Clinical Excellence Awards
- PRA International to Host Audio Conference:
- PRA International Chairs Session on Post Marketing Safety Issues
- PRA International: Participating Sponsor for Exploratory Clinical Development World in London
- PRA Hosts Biotech 2009 - Challenges and Opportunities in R&D
